SV2C: a novel target for inhibition of methamphetamine action
SV2C: a novel target for inhibition of methamphetamine action
批准号:
8718545
负责人:
Kristen Stout
金额:
$4.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2016-05-31
关键词:
AblationAddressAdrenergic AgentsAdverse effectsAnimalsAnxietyAreaAttenuatedBathingBehaviorBehavioralBindingBiological AssayBrainClinical TrialsCognitiveCorpus striatum structureCoupledCouplesCouples TherapyDataDiseaseDopamineDoseDrug AddictionDrug TargetingDrug abuseFamilyGeneticGlycoproteinsHeroin DependenceHigh Pressure Liquid ChromatographyInvestigationLaboratoriesLeadMeasuresMediator of activation proteinMental DepressionMethadoneMethamphetamineMethamphetamine dependenceMicrodialysisMidbrain structureMolecular TargetMotor ActivityMusNatureNeuronsNucleus AccumbensPharmaceutical PreparationsPharmacological TreatmentPlayPositioning AttributeProteinsPsychostimulant dependencePublic HealthRadioactiveRecoveryResearchRewardsRodentRoleScanningSelf AdministrationSignal TransductionSliceSynapsesSynaptic VesiclesTherapeuticTissuesTreatment EfficacyUnited StatesUnited States Substance Abuse and Mental Health Services AdministrationVesicleaddictionadrenergicbasecombatcostdopamine systemdopamine transporterdopaminergic neurondrug developmenteffective therapyextracellulargastrointestinalin vivomeetingsmethamphetamine abusemethamphetamine exposurenerve supplyneurochemistryneurotransmissionneurotransmitter releasenovelnovel therapeuticspreferenceprotein functionpublic health relevanceresearch studyresponsesocialstatisticstherapeutic developmenttherapeutic targettreatment strategyuptakevesicular monoamine transporter
中文摘要
描述(由申请人提供):甲基苯丙胺(冰毒)的成瘾性质至少部分是由于细胞外多巴胺的急剧增加。虽然目前还没有针对冰毒成瘾的治疗方法,但许多化合物已经被研究过在冰毒成瘾康复方面的效果。治疗开发中的困难是找到一种既能调节多巴胺释放又能在多巴胺神经元中优先表达的分子靶点,以限制治疗的不良反应。突触糖蛋白2C(SV2C)的表达主要局限于多巴胺能神经支配丰富的区域,如中脑和纹状体。此外,申请人进行的初步实验证明了SV2C在正常的多巴胺释放和储存中的重要性。通过快速扫描循环伏安法测量,SV2C的遗传消融导致纹状体脑片中的囊泡释放减少50%,通过放射性多巴胺摄取测量,使囊泡存储容量减少20%。SV2C的有限定位,再加上它在多巴胺神经传递中的重要作用,使其成为潜在治疗开发的最佳候选者。这项建议的目的是描述SV2C基因缺失对小鼠服用冰毒相关的神经化学和行为变化的影响。这个项目既及时又具有高度的转化性,因为已经创造了选择性结合SV2C的化合物(UCB Pharma),尽管还没有研究它们对多巴胺信号的调节。
英文摘要
DESCRIPTION (provided by applicant): The addictive nature of methamphetamine (METH) is due, at least in part, to drastically increased extracellular dopamine. Though no current therapeutic for METH addiction is available, numerous compounds have been investigated for efficacy in METH addiction recovery. The difficulty in therapeutic development is finding a molecular target that both modulates dopamine release and is preferentially expressed within dopamine neurons to limit adverse effects of treatment. Expression of the synaptic glycoprotein 2C (SV2C) is largely restricted to areas rich in dopaminergic innervation, such as the midbrain and striatum. Additionally, preliminary experiments conducted by the applicant demonstrate the importance of SV2C in normal dopamine release and storage. Genetic ablation of SV2C results in a 50% reduction of vesicular release in striatal brain slices, as measured by fast scan cyclic voltammetry, and a 20% reduction in vesicular storage capacity, as measured by radioactive dopamine uptake. The restricted localization of SV2C coupled with the important role it plays in dopamine neurotransmission identify it as a prime candidate for potential therapeutic development. The purpose of this proposal is to delineate the effect of genetic deletion of SV2C on the neurochemical and behavioral changes associated with METH administration in mice. This project is both timely and highly translational, as compounds that selectively bind SV2C have been created (UCB Pharma), though they have not been investigated for modulation of dopamine signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estradiol reduces mitochondrial oxidant stress in SNc DA neurons
-
批准号:9755317
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2017
-
负责人:Kristen Stout
-
依托单位:
Estradiol reduces mitochondrial oxidant stress in SNc DA neurons
-
批准号:9591256
-
项目类别:
-
资助金额:$5.9万
-
财政年份:2017
-
负责人:Kristen Stout
-
依托单位:
SV2C: a novel target for inhibition of methamphetamine action
-
批准号:8889500
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2014
-
负责人:Kristen Stout
-
依托单位:
海外基金